Rizaport® - Rizatriptan VersaFilmTM

Rizaport®  -  Rizatriptan VersaFilmTM
Product Description

Rizaport®  is a novel, competitive and differentiated oral thin film formulation of rizatriptan for the acute treatment of migraine. 
Key Licensing Highlights

  • Orally disintegrating film, without need for water, provides exceptional convenience for migraine patients who experience nausea or have trouble swallowing
  • Rizaport®  is the first oral thin film using IntelGenx proprietary drug delivery technology, VersaFilmTM, for the acute treatment of migraine with or without aura
  • Containing rizatriptan, one of the most effective triptans
  • Bioequivalent to Maxalt-MLT® (Merck & Co.)
  • The first rizatriptan oral disintegrating film to achieve approval in the E.U. and pending U.S. FDA approval
  • USPTO has granted a patent protecting Rizaport®  for 15+ years
  • Manufactured at IntelGenx through a bona fide process offering better cost-effectiveness compared to Maxalt-MLT®
  • IntelGenx offers strong expertise in formulation and process development as well as manufacturing capability
  • Strong management team with a proven track record of success in working with commercialization partners
Our commercialization partners are Exeltis, a subsidiarity of the Chemo Group (Spain) and Pharmatronic (Republic of Korea). 

We are currently looking for a partnership or alliance opportunity to commercialize Rizaport® in any territories worldwide apart from Spain and the Republic of Korea. 


  • CA
  • 2015
    On CPHI since


  • CA
  • 2015
    On CPHI since

More Products from IntelGenx (6)

  • VersaFilmTM   -  Oral Film Technology

    Product VersaFilmTM - Oral Film Technology

    VersaFilm™ is our proprietary delivery technology platform that enables the development of pharmaceutical films with potential to improve product performance: • Rapid disintegration without the need for water • Quicker buccal or sublingual absorption • Potential for faster onset of action and incr...
  • VetaFilmTM - Veterinary Oral Film Technology

    Product VetaFilmTM - Veterinary Oral Film Technology

    VetaFilm™ is our proprietary veterinary oral film technology that provides significant market opportunities to improve drug delivery for companion animals. VetaFilm™ research and development services and veterinary oral films provide: • Dose placed directly on oral mucosa or on their f...
  • Development & Manufacturing by Contract

    Product Development & Manufacturing by Contract

    IntelGenx offers full service to foster the growth of its partners. Our State-of-the-art facilities are equipped with the most modem equipment to deliver high-quality, cost-effective film products, while accommodating client requirements at each stage of product development. Int...
  • Tadalafil VersaFilmTM

    Product Tadalafil VersaFilmTM

    Tadalafil film is a new product opportunity formulated using VersaFilm™, IntelGenx’s proprietary thin film technology. 

    Key Licensing Highlights
    • The first oral thin film using IntelGenx proprietary drug delivery technology, VersaFilm™, for erectile dysfunction • Con...
  • Montelukast VersaFilmTM

    Product Montelukast VersaFilmTM

    Montelukast VersaFilm™ is an early stage pipeline opportunity that leverages the VersaFilm™ Technology for the treatment of degenerative diseases of the brain, such as mild cognitive impairment and Alzheimer's disease, the most prominent form of dementia.  IntelGenx is collabo...
  • Loxapine VersaFilmTM

    Product Loxapine VersaFilmTM

    Loxapine oral film utilizes IntelGenx' proprietary VersaFilm™ technology to allow for a fast and safe acting loxapine oral film dosage form, offering significant clinical benefits for patients with agitation associated with schizophrenia & bipolar 1 disorder.

    Key Licensing Highlights q...